Adolescent with an acute psychotic episode and affective symptoms: diagnostic challenges in the context of atypical neurodevelopment: a case report
DOI:
https://doi.org/10.63262/psfyyg77Keywords:
Psicosis, Adolescent, developmental delayAbstract
Introduction: The diagnosis of psychotic disorders in adolescents with a history of neurodevelopmental conditions poses a significant clinical challenge. Symptom overlap and multiple comorbidities can difficult a timely intervention.
Objective: To present the clinical case of an adolescent patient with acute psychotic symptoms, a history of ADHD, psychomotor and language developmental delay, and neonatal hypoxia, highlighting the diagnostic and therapeutic complexity in this population.
Method: Case report.
Results: This is the case of a 16-year-old adolescent with a history of disruptive behavior, psychotic symptoms, episodes of severe psychomotor agitation, hypersexuality, and affective changes, with multiple hospital admissions and a fluctuating clinical course. The diagnostic and therapeutic approaches employed are described, including the combined use of antipsychotics and follow-up through a day hospital program.
Conclusion: This case highlights the importance of a comprehensive and multidisciplinary assessment in adolescents with severe psychiatric symptoms and altered neurodevelopment. Early identification, flexible therapeutic strategies, and close follow-up are essential to achieving clinical stabilization.
Keywords: psychosis, adolescence, ADHD, developmental delay, atypical antipsychotics.
Downloads
References
1. Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry. 2013;54(3):227–46.
2. Kumra S, Schultz D. Early-onset schizophrenia: diagnostic challenges and treatment considerations. Child Adolesc Psychiatr Clin N Am. 2018;27(1):53–72.
3. Dhossche D, Wachtel L, Goetz M. Catatonia in psychiatric illnesses and general medical conditions: a review. Psychiatry Clin Neurosci. 2010;64(5):392–402.
4. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129–36.
5. McClellan J, Stock S. Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013;52(9):976–990.
6. Sharma AN, Pandey GN, Mishra BR. Catatonia: a neurobiological overview. Schizophr Res. 2020;215:45–52.
7. Findling RL, Drury SS, Jensen PS, Rapoport JL. Psychopharmacology for children and adolescents with major psychiatric disorders. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. 10th ed. Philadelphia: Wolters Kluwer; 2017. p. 3492–3515.
8. Stepanova E, Findling RL. Psychopharmacology of bipolar disorder in children and adolescents. Pediatr Clin North Am. 2011;58(6):173–187.
9. Pavuluri MN, Henry DB, Devineni B, Carbray JA, Birmaher B. Child Mania Rating Scale: development, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 2006;45(5):550–560.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Juan Felipe Garavito Chilatra, Maria Fernanda Bonilla Osorio (Autor/a)
This work is licensed under a Creative Commons Attribution 4.0 International License.
